Part, Chapter, Paragraph
1 II, 5. 2. 3| stroke mortality were more favourable in Central and Southern
2 II, 5. 2. 3| has contributed to this favourable trend.~In contrast, the
3 II, 5. 2. 4| levels of risk factors at a favourable level throughout our life.~ ~
4 II, 5. 2. 5| low risk to maintain this favourable level during their life.
5 II, 5. 2. 5| preferential use of fats with favourable effects on the lipid profile (
6 II, 5. 3. 7| screening about both the favourable and unfavourable effects
7 II, 5. 5. 3| identify drugs that may have favourable effects on suicidality.~
8 II, 5. 12. 1| immediate instrument to obtain a favourable impact on cirrhosis.~In
9 II, 5. 12. 3| countries diverged from the favourable trends of cirrhosis mortality
10 II, 5. 12. 3| cirrhosis shows a general favourable trend in several countries
11 II, 5. 12. 3| may also have had some favourable impact on mortality from
12 II, 5. 12. 4| 2006a), and the subsequent favourable trends followed the decline
13 II, 5. 12. 5| immediate instrument to obtain a favourable impact on cirrhosis (mortality),
14 II, 5. 12. 5| infection will also have favourable impacts to control this
15 II, 5. 12. 5| However, at least part of the favourable trends observed in Southern
16 II, 5. 12. 6| Thus, at least part of the favourable impact of transplantation
17 II, 5. 14. 2| help assure quality and favourable outcomes, and extend more
18 II, 6. 3. 7| France not reporting). The favourable trend in recent years contrasts
19 II, 7. 6 | and work place and less favourable at home and during leisure
20 II, 8. 2. 1| health conditions, less favourable social circumstances typically
21 III, 10. 4. 2| outcome of the evaluation is favourable will be authorised for use
22 III, 10. 6. 2| social security~3. Secure and favourable conditions during childhood
23 IV, 11. 5. 1| matching and the resultant favourable results of organ transplantation,
24 IV, 11. 5. 4| advances, strong evidence of favourable transplant outcome and low
25 IV, 11. 6. 2| strong incentives to select favourable risks.~ ~Most countries
26 IV, 11. 6. 2| which may or may not be favourable. On the other hand, earmarked
27 IV, 12. 2 | preferential use of fats with favourable effects on the lipid profile (
28 IV, 12. 10 | environmental conditions favourable to health.~Smoking and tobacco
29 IV, 12. 10 | social security~3. Secure and favourable conditions during childhood
30 IV, 13. 7. 3| health research will be more favourable than in the previous FP
